The FDA made a few changes to Propecia and Proscar which include:
- a revision to the Propecia label to include libido disorders, ejaculation disorders, and orgasm disorders that continued after discontinuation of the drug,
- a revision to the Proscar label to include decreased libido that continued after discontinuation of the drug, and
- a revision to both the Propecia and Proscar labels to include a description of reports of male infertility and/or poor semen quality that normalized or improved after drug discontinuation.
